Culturally adapted CBT plus Problem-solving therapy with Afghan Refugees: a pilot study

Culturally adapted CBT plus Problem-solving therapy with Afghan Refugees: a pilot study - CACBT+

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016154

Enrollment

Registered

2018-12-19

Start date

2018-12-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1 F32.1 F41.0 F41.1

Interventions

Group 1: Arm 1: CACBT is evaluated through a randomized controlled design. The control group is a waitlist group (Care-as-usual). After recruitment patients undergo T1. After patients are randomly ass

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: - Age above 18 years - Country of origin Iran or Afghanistan - Diagnosis of a psychic disorder according to the DSM-5

Exclusion criteria

Exclusion criteria: - Severe suicidality - acute psychosis - current psychotherapy - addiction

Design outcomes

Primary

Measure	Time frame
Within the assessment only validated, clinically and transculturally established instruments will be used. The primary outcome of CACBT is a clinically significant reduction of the GHQ-28 (-5). The GHQ-28 assesses general psychopathological symptoms within the areas of anxiety/insomnia, social functioning, severe depression, somatic complaints. The GHQ-28 will be assessed three times, T1, T2 and Follow up.	—

Measure

Time frame

Within the assessment only validated, clinically and transculturally established instruments will be used. The primary outcome of CACBT is a clinically significant reduction of the GHQ-28 (-5). The GHQ-28 assesses general psychopathological symptoms within the areas of anxiety/insomnia, social functioning, severe depression, somatic complaints. The GHQ-28 will be assessed three times, T1, T2 and Follow up.

—

Secondary

Measure	Time frame
The following areas were defined as secondary outcomes (these will equally be assessed at three times, t1, t2 and follow up): Specific depression symptoms according to the DSM-V, process variables as emotional distancing, trauma specific symptoms, quality of life, social relationships. For assessing the quality of life and social relationships the WHO quality of life brief version (WHOQOL bref) will be used. Depression will be assessed by the PHQ9. The PCL5 assesses trauma symptoms. Emotion Regulation Questionnaire assesses the ability of emotional distancing.	—

Measure

Time frame

The following areas were defined as secondary outcomes (these will equally be assessed at three times, t1, t2 and follow up): Specific depression symptoms according to the DSM-V, process variables as emotional distancing, trauma specific symptoms, quality of life, social relationships. For assessing the quality of life and social relationships the WHO quality of life brief version (WHOQOL bref) will be used. Depression will be assessed by the PHQ9. The PCL5 assesses trauma symptoms. Emotion Regulation Questionnaire assesses the ability of emotional distancing.

—

Countries

Germany

Contacts

Public ContactSchahryar Kananian

Goethe-Universität Frankfurt

kananian@psych.uni-frankfurt.de06979825367

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026